UK gets social media presence

Share this article:
The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued “informal guidance” on digital communications, and while it's more than FDA has offered, it's not much to go on.
The guidance, which takes the form of a Q&A, is mainly an interpretation of the industry's Code of Practice applied to social media and the internet. Short version: as in any other medium, companies can communicate only non-promotional information about products to the public, and only in response to a direct inquiry. However, the guidance does suggest that companies could post more basic product info on their websites.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...